HUNTERSVILLE, N.C.--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ: OFIX - News) (the Company) announced today that it has completed the process of exploring options related to the potential divestiture of certain fixation assets in its orthopedic division. After careful consideration of the respective offers, the Board of Directors and management decided it was not in the best interest of our shareholders to proceed with any transaction. Orthofix indicated that as an alternative to the divestiture of its fixation assets it is taking steps designed to improve the operating efficiency and profitability of its orthopedic business, including the optimization of product offerings within each of the Company’s global markets. Additionally, Orthofix reiterated its previously released full year 2008 revenue guidance of $520-$540 million, as well as its full year earnings guidance. This included earnings guidance of $1.45-$1.60 per diluted share on a GAAP basis, $2.00-$2.15 of adjusted net income per diluted share and $3.10-$3.30 per diluted share of adjusted net income, excluding specified non-cash items. This excludes any financial impact associated with the completion of the divestiture process, which will be discussed during the Company’s conference call scheduled for May 1st to review financial results for the first quarter of 2008.
